Mandate

Vinge advises BHG Group in connection with the acquisition of HYMA Skog & Trädgård

Vinge is advising BHG Group AB (publ) in connection with its acquisition of 92.2% of the shares in HYMA Skog & Trädgård (“HYMA”). The initial purchase price for 100% of the shares is equivalent to approximately MSEK 1,100, which will be paid partly in cash and partly through an issue in kind. In addition, there is an earn-out based on EBITA for 2022 of up to SEK 500 million. Pursuant to the issue in kind, the current principal shareholder Verdane and HYMA’s management will become shareholders in BHG Group

HYMA holds a leading market position within the categories of Gardening, Tools and Leisure with a broad portfolio of external and own brands. The company’s turnover for the entire year 2021 is expected to amount to approximately MSEK 1,100 with an EBITA of MSEK 80.

 

BHG Group is the largest online actor within consumer trading in the Nordic region and the largest online actor in Europe within Home Improvement, which includes both Do-It-Yourself and Home Furnishing. BHG Group’s e-trading operations employs approximately 2,000 people and includes more than 100 online destinations and 70 showrooms. The head office is situated in Malmö with operations in most European countries. BHG Group is listed on Nasdaq Stockholm.

 

The transaction is subject to customary approvals by public authorities.

 

Vinge’s team consists of Kristian Ford together with, among others, Pär Remnelid (competition law), Christian Lindhé (capital markets), Niklas Törnell, Julia Ahlqvist, Karin Gynnerstedt, Lena Westberg, Tilda Hall and Selma Beganovic.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026